Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04450706 · ClinicalTrials.gov registry record · NA
Functional Precision Oncology for Metastatic Breast Cancer
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04450706 is a NA study that has completed, run by University of Utah. The registered enrollment target is 15 participants.
The verdict
NCT04450706, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a pilot study to assess the feasibility of comprehensive genomic characterization and drug screening in metastatic breast cancer. The trial will seek to provide personalized genomic and drug sensitivity information to eligible patients with metastatic breast cancer prior to disease progression on standard treatment. The trial will also explore how these results influence physician selection of next-line therapy.
Interventions
- OTHER Precision Medicine
- OTHER Physican Decision Making
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2024-09-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04450706
The ClinicalTrials.gov registry entry for NCT04450706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Precision Medicine is the first listed.
NCT04450706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04450706 about?
NCT04450706 is a clinical study titled "Functional Precision Oncology for Metastatic Breast Cancer". This is a pilot study to assess the feasibility of comprehensive genomic characterization and drug screening in metastatic breast cancer. The trial will seek to provide personalized genomic and drug sensitivity information to eligible patients with metastatic breast cancer prior to disease progressi...
What is the current status of trial NCT04450706?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-02-16. Estimated completion is 2024-09-05.
What interventions are being tested in trial NCT04450706?
The interventions under investigation include: Precision Medicine (OTHER), Physican Decision Making (OTHER).
Who is sponsoring clinical trial NCT04450706?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.